Advanced search
Publication Cover
British Journal of Biomedical Science Volume 75, 2018 - Issue 1
Journal homepage
133
Views
4
CrossRef citations to date
0
Altmetric
Biomedical Science in Brief

p53 and miR-34b/c genetic variation and their impact on ulcerative colitis susceptibility

Z HosseinpourFaculty of Sciences, Department of Biology, University of Guilan, Rasht, Iran
,
Z SalehiFaculty of Sciences, Department of Biology, University of Guilan, Rasht, Iran
,
S Talesh SasaniFaculty of Sciences, Department of Biology, University of Guilan, Rasht, IranCorrespondence[email protected]
&
K AminianResearch Center for Gastroenterology and Liver Diseases, Razi Hospital, Guilan University of Medical Sciences, Rasht, Iran
Pages 46-49 | Received 06 Jun 2017, Accepted 27 Jul 2017, Published online: 21 Sep 2017

References

  • Yashiro M. Ulcerative colitis-associated colorectal cancer. World J Gastroenterol. 2014;20(44):16389–16397. DOI:10.3748/wjg.v20.i44.16389.
  • Maloy kJ, Powrie F. Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature. 2011;474(7351):298–306. DOI:10.1038/nature10208.
  • Volodko N, Salla M, Eksteen B, et al. TP53 codon 72 Arg/Arg polymorphism is associated with a higher risk for inflammatory bowel disease development. World J Gastroenterol. 2015;21(36):10358–10366. DOI:10.3748/wjg.v21.i36.10358.
  • Pérez LO, Abba MC, Dulout FN, et al. Evaluation of p53 codon 72 polymorphism in adenocarcinomas of the colon and rectum in La Plata. Argentina. World J Gastroenterol. 2006;12(9):1426–1429.10.3748/wjg.v12.i9.1426
  • Storey A, Thomas M, Kalita A, et al. Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature. 1998;393(6682):229–234. DOI:10.1038/30400.
  • He L, He X, Lim LP, et al. A microRNA component of the p53 tumour suppressor network. Nature. 2007;447(7148):1130–1134.10.1038/nature05939
  • Xu Y, Liu L, Liu J, et al. A potentially functional polymorphism in the promoter region of miR-34b/c is associated with an increased risk for primary hepatocellular carcinoma. Int J Cancer. 2011;128(2):412–417. DOI:10.1002/ijc.25342.
  • Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med. 1987;317(26):1625–1629. DOI:10.1056/NEJM198712243172603.
  • Vietri MT, Riegler G, Ursillo A, et al. p53 codon 72 polymorphism in patients affected with ulcerative colitis. J Gastroenterol. 2007;42(6):456–460. DOI:10.1007/s00535-007-2026-z.
  • Vaji S, Salehi Z, Aminian K. Association of p53 codon 72 genetic polymorphism with the risk of ulcerative colitis in northern Iran. Int J Colorectal Dis. 2011;26(2):235–238. DOI:10.1007/s00384-010-1021-7.
  • Triantafillidis JK, Nasioulas G, Kosmidis PA. Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies. Anticancer Res. 2009;29(7):2727–2737.
  • Corney DC, Flesken-Nikitin A, Godwin AK, et al. MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth. Cancer Res. 2007;67(18):8433–8438. DOI:10.1158/0008-5472.CAN-07-1585.
  • Bensen JT, Tse CK, Nyante SJ, et al. Association of germline microRNA SNPs in pre-miRNA flanking region and breast cancer risk and survival: the Carolina Breast Cancer Study. Cancer Causes Control. 2013;24(6):1099–1109. DOI:10.1007/s10552-013-0187-z.
  • Yadegari ZS, Akrami H, Hosseini SV, et al. miR-146a gene polymorphism and susceptibility to gastric cancer. Br J Biomed Sci. 2016;73(4):201–203. DOI:10.1080/09674845.2016.1233790.
  • Ren X, Shen Y, Zheng S, et al. miR-21 predicts poor prognosis in patients with osteosarcoma. Br J Biomed Sci. 2016;73(4):158–162. DOI:10.1080/09674845.2016.1220710.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.